ArticlePloS one2019

Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib.

Ethan Poteet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.